Logo

• Finished gynecological cancer (KGOG3022S1)

  Evaluation of modes to predict optional cytoreduction in advanced- stage ovarian cancer:KGOG3022 ancillary study

  • PI / PI기관 Jung-Yun Lee /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 0 person (0.0%)

• Finished gynecological cancer (KGOG3022)

  Retrospective-Image-based prediction model for surgical cytoreduction in advanced ovarian cancer

  • PI / PI기관 Sokbom Kang /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 358 person / 667 person (53.7%)

• Finished gynecological cancer (KGOG3017)

  A Phase II randomized controlled clinical trial of carboplatin and paclitaxel or carboplatin and gemcitabin in platinum-sensitive, recurrent ovarian, fallopian tube, and primary peritoneal cancer

  • PI / PI기관 Seung Cheol Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 9 person / 314 person (2.9000000000000004%)

• Finished gynecological cancer (KGOG3016)

  • PI / PI기관 Yong Man Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 18 person (0.0%)

• Finished gynecological cancer (KGOG3014)

  GOG-218: A phase III trial of carboplatin & paclitaxel plus placebo vs carboplatin & paclitaxel plus concurrent bevacizumab followed by placebo, vs carboplatin & paclitaxel plus concurrent & extended bevacizumab, in women with newly diagnosed, previously untreated, state III or IV, epithelial ovarian, primary peritoneal tube cancer

  • PI / PI기관 Soon-Beom Kang /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 1902 person / 1800 person (105.69999999999999%)

• Finished gynecological cancer (KGOG3013)

  Retrospective-Primary peritoneal carcinoma vs EOC

  • PI / PI기관 Byoung-Gie Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 0 person (0.0%)

• Finished gynecological cancer (KGOG3012)

  Retrospective-Clinical feature of brain metastasis in ovarian cancer

  • PI / PI기관 Byoung-Gie Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-07-06
  • Current Enrollment / Estimated Enrollment 0 person / 0 person (0.0%)

• Finished gynecological cancer (KGOG3011)

  GCIG/JGOG 3017: Randomized Phase III Trial of Paclitaxel plus Carboplatin (TC) Therapy versus Irinotecan plus Cisplatin (CPT-P) Therapy as a First Line Chemotherapy for Clear Cell Carcinoma of the Ovary

  • PI / PI기관 Jae-Weon Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 25 person / 662 person (3.8%)

• Finished gynecological cancer (KGOG3010)

  An Open-label, Multi-center, Randomized Phase III Trial of Intraperitoneal Paclitaxel as Consolidation Chemotherapy in Patients with Advanced Epithelial Ovarian Carcinoma

  • PI / PI기관 Byoung-Gie Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 202 person (0.0%)

• Finished gynecological cancer (KGOG3009)

  A Phase II Clinical Trial of TEP(paclitaxel, etoposide and cisplatin) chemotherapy in patients with Intermediate / Poor Prognosis malignant Ovarian Germ Cell Tumors

  • PI / PI기관 Ki Heon Lee /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 51 person (0.0%)

* (사)대한부인종양연구회는 게시된 세부 임상연구 정보에 대해 법적 책임이 없습니다.